Effective tissue procurement and utilization is vital for meaningful translational research activities. The Tissue Procurement and Pathology Core will work with each SPORE project and the Biostatistics and Data Management Core to ensure efficient and highly coordinated procurement, use and storage of human tissue samples. The Core will obtain and maintain a repository of tissue samples (including tumor tissue, premalignant tissue, adjacent non-malignant tissue, peripheral blood lymphocytes and surrogate tissues) for laboratory use, with an effective coding system for all laboratory specimens to ensure patient confidentiality and prevent experimental bias. Continuous communication between the surgeons, research nurses, biostatisticians and pathologists, as well as standardized operating procedures for activities will provide for optimal tissue collection and accurate processing, analysis and storage of each sample. Thus, the functions of the Tissue Procurement and Pathology Core are to facilitate acquisition, preservation, analysis and dispersal of clinical samples and to provide histopathologic characterization of tumor tissues for all project investigators. The Tissue Procurement, and Pathology Core has the following objectives: Objective 1. Develop and maintain repository of tissue specimens from patients with head and neck cancer or oral premalignancies receiving care or evaluation at M.D. Anderson Cancer Center Objective 2. Provide comprehensive histologic characterization of tissue samples used in SPORE projects, including specimens from patients entered onto clinical protocols;expeditiously distribute tissue specimens to SPORE investigators for analysis and provide expertise in the interpretation of studies performed on tissue sections within SPORE projects Objective 3. Offer centralized services, including immunohistochemical characterization of biomarkers, manual and laser capture microdissection, tissue array design and construction, fiow cytometry and cell sorting, and provision and utilization of specialized DNA arrays Objective 4. Maintain a comprehensive, prospective interactive database with detailed clinical and pathologic data for patients with head and neck cancer or oral premalignancies receiving care or evaluation at M.D. Anderson Cancer Center Objective 5. Facilitate inter-SPORE collaborations through sharing of tissue resources

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA116199-05
Application #
7906046
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
2012-08-31
Budget Start
2009-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$142,634
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Nanos-Webb, A; Bui, T; Karakas, C et al. (2016) PKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene 35:2428-40
Jabbour-Leung, Natalie A; Chen, Xian; Bui, Tuyen et al. (2016) Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther 15:593-607
Lucenay, Kimberly S; Doostan, Iman; Karakas, Cansu et al. (2016) Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res 76:2406-18
Gaur, Sanchaika; Wen, Yunfei; Song, Jian H et al. (2015) Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget 6:29161-77
Wen, Yunfei; Graybill, Whitney S; Previs, Rebecca A et al. (2015) Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer. Clin Cancer Res 21:448-59
Qi, Yuan; Liu, Xiuping; Liu, Chang-Gong et al. (2015) Reproducibility of Variant Calls in Replicate Next Generation Sequencing Experiments. PLoS One 10:e0119230
Guan, Xiaoxiang; Liu, Hongliang; Ju, Jingfang et al. (2015) Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ? 55 years. Mol Carcinog 54:281-90
Gutierrez-Rubio, S A; Quintero-Ramos, A; Durán-Cárdenas, A et al. (2015) 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res 14:1250-9
Nodora, Jesse N; Cooper, Renee; Talavera, Gregory A et al. (2015) Acculturation, Behavioral Factors, and Family History of Breast Cancer among Mexican and Mexican-American Women. Womens Health Issues 25:494-500
Wen, Yunfei; Zand, Behrouz; Ozpolat, Bulent et al. (2014) Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell Rep 7:488-500

Showing the most recent 10 out of 137 publications